Lifecore Biomedical, Inc. \De\ financial data

Symbol
LFCR on Nasdaq
Industry
Pharmaceutical Preparations
Location
3515 Lyman Boulevard, Chaska, MN
State of incorporation
DE
Fiscal year end
May 26
Former names
LANDEC CORP \CA\ (to 11/7/2022)
Latest financial report
10-K - Q2 2024 - Aug 26, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 209 % +133%
Quick Ratio 108 % +208%
Debt-to-equity 4.8K % +1014%
Return On Assets 4.85 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.9M shares
Common Stock, Shares, Outstanding 30.6M shares +0.8%
Entity Public Float 154M USD -15%
Common Stock, Value, Issued 30K USD 0%
Weighted Average Number of Shares Outstanding, Basic 30.5M shares +1.72%
Weighted Average Number of Shares Outstanding, Diluted 36.7M shares +22.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.58M USD -1.84%
Operating Income (Loss) -8.84M USD +59.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9.51M USD +80.6%
Income Tax Expense (Benefit) 183K USD -40.6%
Net Income (Loss) Attributable to Parent 12M USD +82%
Earnings Per Share, Basic 0.4 USD/shares +82.6%
Earnings Per Share, Diluted 0.32 USD/shares +89.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.46M USD -55.7%
Accounts Receivable, after Allowance for Credit Loss, Current 31.2M USD +7.34%
Inventory, Net 40M USD -2.11%
Assets, Current 81M USD -13.7%
Property, Plant and Equipment, Net 149M USD +10.6%
Operating Lease, Right-of-Use Asset 2.44M USD -43%
Intangible Assets, Net (Excluding Goodwill) 4.2M USD 0%
Goodwill 13.9M USD 0%
Other Assets, Noncurrent 3.81M USD +30.5%
Assets 254M USD +0.16%
Accounts Payable, Current 16.3M USD -26.1%
Employee-related Liabilities, Current 5.53M USD +33.5%
Contract with Customer, Liability, Current 3.2M USD +18%
Liabilities, Current 38.9M USD -1.06%
Contract with Customer, Liability, Noncurrent 4.7M USD +60%
Deferred Income Tax Liabilities, Net 543K USD +42.9%
Operating Lease, Liability, Noncurrent 1.73M USD -73.4%
Other Liabilities, Noncurrent 5.09M USD +2823%
Liabilities 200M USD -8.42%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -167M USD +6.73%
Stockholders' Equity Attributable to Parent 11.3M USD
Liabilities and Equity 254M USD +0.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.33M USD -656%
Net Cash Provided by (Used in) Financing Activities 2.93M USD -24.9%
Net Cash Provided by (Used in) Investing Activities -5.05M USD -2136%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 30.6M shares +0.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.4M USD -505%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.46M USD -55.7%
Deferred Tax Assets, Valuation Allowance 46.2M USD -12.1%
Deferred Tax Assets, Gross 65.9M USD -0.68%
Operating Lease, Liability 5.69M USD -25.5%
Payments to Acquire Property, Plant, and Equipment 5.05M USD +50.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12M USD +82%
Lessee, Operating Lease, Liability, to be Paid 5.9M USD -34%
Property, Plant and Equipment, Gross 199M USD +3.94%
Operating Lease, Liability, Current 3.96M USD +245%
Lessee, Operating Lease, Liability, to be Paid, Year Two 433K USD -64.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.02M USD +174%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure -43.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 211K USD -83.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 416K USD -66.1%
Deferred Tax Assets, Operating Loss Carryforwards 40.8M USD -8.54%
Preferred Stock, Shares Issued 42K shares +7.69%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 1.27M USD +8.36%
Lessee, Operating Lease, Liability, to be Paid, Year Four 302K USD -75.5%
Additional Paid in Capital 178M USD +2.03%
Preferred Stock, Shares Outstanding 42.5K shares +7.71%
Depreciation, Depletion and Amortization 2.17M USD -50.2%
Deferred Tax Assets, Net of Valuation Allowance 19.7M USD +42.5%
Share-based Payment Arrangement, Expense 6.2M USD +71.7%
Interest Expense 17.6M USD +13.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%